ARS Pharmaceuticals recently reported that the European Medicines Agency’s CHMP issued a positive opinion to expand EURneffy’s marketing authorization to include a 1 mg nasal adrenaline spray for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results